No Prescription |
 |
 | ||
|
Nicotinell TTS 30 Generic Nicotine |
|
| ||
No Prescription » Prescription Drugs 11 » Nicotinell TTS 30 Generic Nicotine Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Nicotinell TTS patches contain nicotine. They are a type of medicine known as nicotine replacement therapy (NRT) and are used to help smokers give up the habit.Nicotine is the addictive substance present in tobacco. Smokers who try to give up often experience unpleasant withdrawal symptoms and cravings for cigarettes because they are dependent on the nicotine in tobacco. Withdrawal symptoms can include irritability headaches restlessness insomnia and difficulty concentrating. These combined with cigarette cravings are why it is difficult for some people to give up smoking.Nicotine replacement therapies work by giving you a small amount of nicotine but without the dangerous effects of inhaling tobacco smoke. This helps relieve the withdrawal symptoms and cravings for a cigarette that you get when you stop smoking and allows you to get on with breaking the psychological habit of smoking. If you are physically addicted to nicotine using NRT has been shown to almost double your chances of successfully quitting smoking.Medical InformationNicotinell patches are worn continuously for 24 hours. The nicotine in the patches is absorbed continuously through the skin into the bloodstream. This produces a lower amount of nicotine in the blood than smoking but the continuous level is enough to help prevent the withdrawal symptoms and cravings that you get after you stop smoking.The patches come in three different sizes: 30cm2 20cm2 and 10cm2. These contain 21mg 14mg and 7mg of nicotine respectively. People who smoke more than 20 a day should start with the 30cm2 size. One patch should be applied at the same time every day usually in the morning and replaced after 24 hours. (You can remove the patch before going to bed but leaving it on overnight will reduce your morning cravings.) If you have managed not to smoke after three to four weeks of using the 30cm2 patches you should then drop down to the 20cm2 patches for three to four weeks and finally the 10cm2 patches for three to four weeks. People who smoke less than twenty cigarettes a day should start with the 20cm2 patches. Reducing the patch size in this way gradually weans you off the nicotine allowing you to focus on breaking the smoking habit. By the time you stop using the patches your psychological urge to smoke should be reduced.NRT comes in many forms. There are factsheets on all these linked at the end of this page. Nicotine patches are used to help prevent cravings for cigarettes while nasal sprays inhalators chewing gum tablets that dissolve under the tongue and lozenges are all forms that can be used instead of smoking when you get a cigarette craving.As well as breaking the physical addiction you also need to break the smoking habits you used to have. Try to avoid situations where you will be tempted to smoke and remember to seek help and support whenever you feel like giving in to your cravings.What is it used for?Relief of withdrawal symptoms associated with giving up smoking. Buy Nicotinell TTS 30 Generic Nicotine and other Prescription Drugs 11 products online at Medstore. 4991
About Nicotinell TTS 30 Generic Nicotine: Product Type: Prescription Drugs 11 Nicotinell TTS-30 ( Generic Nicotine ) Nicotinell TTS-30 (Generic Nicotine) Generic Nicotine 52 5 mg 7 patches Generic Nicotine Nicotinell TTS-30
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
